Fidelity Bank’s Capital Raise Bought Solvency, Not Conviction
Fidelity Bank’s stock at ₦21.00-₦21.90 in mid-May 2026 looks cheap at first glance, and that’s exactly why it’s getting attention. Trading at roughly 4.1x earnings against a banking sector average of 7-9.5x, it sits at a steep discount to GTCO at ₦144, Zenith at ₦128.50, and Access which is leading volume on the NGX. The gap isn’t accidental. The market is pricing in both the dilution from Fidelity’s December 2025 private placement and the ₦223.8B derivative loss that dragged FY 2025 profit after tax down 12.8%. Those two events turned what could have been a clean re-rating story into something messier.
Strip out the trading loss and the picture changes. Core banking operations grew revenue 45.6% year-on-year to ₦1.52T, deposits climbed 16.1% to ₦6.89T, and fee income jumped 44.7%. Assets are now above ₦10.46T and shareholders’ funds crossed ₦1T for the first time. The December capital raise pushed eligible capital to ₦532.6B, putting Fidelity comfortably above the CBN’s ₦500B threshold for internationally authorized banks. If management can deploy that capital into lending, the 2.4% dip in the loan book last year should reverse, and the revenue momentum has room to compound.
But the market cares about per-share outcomes, not just topline growth, and here the tension shows. EPS surged from ₦3.11 in FY 2023 to ₦8.69 in FY 2024, only to take a hit in FY 2025 as dilution and trading losses eroded profit quality. The decision to skip a dividend for FY 2025 broke a 15-year streak and alienated income investors who’ve shifted to Zenith and GTCO, both of which paid substantial final dividends and continue to anchor institutional flows. GTCO’s market cap now sits at ₦5.26T with foreign portfolio investors citing lower keyman risk, while Zenith recently closed above GTCO for the first time since 2009 on the back of higher profitability and dividend yield. Compared to those names, Fidelity offers a deeper discount but with more volatility in earnings and no yield to cushion downside.
Technically, the stock has been a momentum play. After bouncing off ₦19 in late April, it broke ₦21 and is pressing against resistance near ₦24.25. The Banking Index led the broader market rally, with the NGX ASI crossing 250,000 for the first time and gaining nearly 61% year-to-date. In that environment, high-beta names like Fidelity get bid first, which explains the “Strong Buy” signal from technical indicators and the 9% gain in four weeks. Yet the move feels retail-driven, sensitive to sentiment around earnings quality and dividend policy. Buyers waiting for a dip to ₦19-20 are betting that the post-results weakness hasn’t fully flushed out, while the ₦25+ price targets assume no repeat of derivative losses and that the new capital starts showing up in loan growth.
The next few quarters will decide which narrative wins. Q1 2026 results will tell whether the derivative losses were truly one-off and if fee income can sustain its 40%+ growth rate. Loan book expansion would signal that the capital raise is being put to work, not just sitting on the balance sheet. Any guidance on resuming dividends would matter more than it would for GTCO or Zenith because Fidelity has no income buffer to fall back on. Without it, the stock remains a high-beta bet on the broader banking recovery rather than a compounder.
So the case for Fidelity is conditional. For value investors, the 4.1x P/E only makes sense if FY 2025 was an anomaly and earnings normalize without another trading hit. For traders, the ₦21-24 range offers a tradeable move, but it’s more exposed to sector rotation than the tier-1 banks. Right now, GTCO and Zenith are priced for stability and yield, Access is priced for liquidity and scale, and Fidelity is priced for uncertainty. The discount is real, but so is the reason for it. Whether that changes depends less on revenue growth and more on whether Fidelity can prove its earnings quality is catching up.
